High Tumor Mutational Burden Correlates with Longer Survival in Immunotherapy-Naïve Patients with Diverse Cancers.
Riviere P, Goodman AM, Okamura R, Barkauskas DA, Whitchurch TJ, Lee S, Khalid N, Collier R, Mareboina M, Frampton GM, Fabrizio D, Sharabi AB, Kato S, Kurzrock R.
Riviere P, et al. Among authors: sharabi ab.
Mol Cancer Ther. 2020 Oct;19(10):2139-2145. doi: 10.1158/1535-7163.MCT-20-0161. Epub 2020 Aug 3.
Mol Cancer Ther. 2020.
PMID: 32747422
Free PMC article.